Table 3 Reasons for reluctance for HPV vaccination between the intervention and control groups before and after the intervention
Reasons for against HPV vaccination | Pre-intervention | Post-intervention | |||||
|---|---|---|---|---|---|---|---|
All, n (%) | Control group, n (%) | Intervention group, n (%) | p | Control group, n (%) | Intervention group, n (%) | p | |
Expense of vaccines | 366 (57.7) | 168 (56.9) | 198 (58.4) | 0.711 | 152 (58.7) | 160 (68.1) | 0.031 |
Possible adverse events of HPV vaccine | 355 (56.0) | 167 (56.6) | 188 (55.5) | 0.771 | 156 (60.2) | 107 (45.5) | 0.001 |
No sexual activity | 243 (38.3) | 112 (38.0) | 131 (38.6) | 0.861 | 93 (35.9) | 95 (40.4) | 0.302 |
Doubts on safety and efficacy of HPV vaccine | 237 (37.4) | 111 (37.6) | 126 (37.2) | 0.905 | 111 (42.9) | 63 (26.8) |  < 0.001 |
Fear of needling pain | 133 (21.0) | 68 (23.1) | 65 (19.2) | 0.232 | 59 (22.8) | 50 (21.3) | 0.687 |
Vaccination is troublesome | 130 (20.5) | 51 (17.3) | 79 (23.3) | 0.061 | 40 (15.4) | 46 (19.6) | 0.227 |